RA Capital Management, L.P. 13D and 13G filings for Apogee Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-14 5:46 pm Sale |
2024-09-30 | 13G | Apogee Therapeutics, Inc. APGE |
RA Capital Management, L.P. | 1,961,863 3.400% |
-16,038 (-0.81%) |
Filing |
| 2024-02-14 5:01 pm Purchase |
2023-12-31 | 13G | Apogee Therapeutics, Inc. APGE |
RA Capital Management, L.P. | 1,977,901 5.300% |
1,977,901 (New Position) |
Filing |